EchoNous

EchoNous

Pre-clinical
Redmond, United StatesFounded 2016echonous.com

Founded in 2016 and headquartered in Redmond, Washington, EchoNous is a private, well-funded startup on a mission to redefine point-of-care ultrasound by fusing premium imaging, extreme portability, and industry-leading artificial intelligence. The company's Kosmos ecosystem offers a suite of ultraportable devices and software solutions designed to improve diagnostic accuracy, streamline workflows, and accelerate learning for both novice and expert users. With a seasoned leadership team from industry giants like SonoSite, Medtronic, and Siemens, EchoNous is commercializing its technology across numerous medical specialties globally.

Founded
2016

AI Company Overview

Founded in 2016 and headquartered in Redmond, Washington, EchoNous is a private, well-funded startup on a mission to redefine point-of-care ultrasound by fusing premium imaging, extreme portability, and industry-leading artificial intelligence. The company's Kosmos ecosystem offers a suite of ultraportable devices and software solutions designed to improve diagnostic accuracy, streamline workflows, and accelerate learning for both novice and expert users. With a seasoned leadership team from industry giants like SonoSite, Medtronic, and Siemens, EchoNous is commercializing its technology across numerous medical specialties globally.

Technology Platform

The Kosmos Platform integrates ultraportable, cart-benchmarked ultrasound hardware with a proprietary deep-learning AI engine for real-time probe guidance, image quality grading, and automated clinical analysis (e.g., cardiac function, bladder volume).

Funding History

3

Total raised: $37.5M

Series B$25MUndisclosedJun 15, 2021
Series A$10MUndisclosedJun 15, 2018
Seed$2.5MUndisclosedJun 15, 2015

Opportunities

Significant growth opportunity lies in capturing market share in the expanding global POCUS market by addressing multiple high-volume clinical specialties with a differentiated AI-integrated platform.
Further expansion into telemedicine via partnerships and development of new AI-driven workflow solutions present adjacent growth vectors.

Risk Factors

Key risks include intense competition from large, established medtech firms and well-funded pure-plays, the challenge of driving widespread clinical adoption of AI-assisted diagnostics, and the execution risks associated with scaling a global sales operation as a private company dependent on external funding.

Competitive Landscape

EchoNous competes with giants like Philips, GE HealthCare, and Fujifilm SonoSite, as well as tech-focused players like Butterfly Network. Its differentiation is based on offering advanced Doppler capabilities in an ultraportable form factor, combined with a proprietary, integrated AI platform for guidance and automation, at a competitive price point.

Company Info

TypeDiagnostics
Founded2016
LocationRedmond, United States
StagePre-clinical
RevenueRevenue Generating

Therapeutic Areas

Emergency MedicineCritical CareCardiologyFamily MedicineAnesthesiologyOB/GYNVascular AccessNephrologyMusculoskeletalPrimary CareNursing

Partners

Us2.ai19 LabsTrice Imaging
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile